Intengan ME - Search Results

1

S-phase modulation by irinotecan: pilot studies in advanced solid tumors.

Ramnath N, Khushalani N, Toth K, Litwin AM, Intengan ME, Slocum HK, Pendyala L, Smith PF, Stewart CC, Hoffman JL, Javle MM, Berdzik J, Creaven PJ, Rustum YM. Ramnath N, et al. Among authors: intengan me. Cancer Chemother Pharmacol. 2005 Nov;56(5):447-54. doi: 10.1007/s00280-004-0951-6. Epub 2005 Jun 10. Cancer Chemother Pharmacol. 2005. PMID: 15947933 Clinical Trial.

2

NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, Williamson B, Scanlan MJ, Ritter G, Chen YT, Driscoll D, Sood A, Lele S, Old LJ. Odunsi K, et al. Cancer Res. 2003 Sep 15;63(18):6076-83. Cancer Res. 2003. PMID: 14522938

3

Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics.

Odunsi K, Wollman RM, Ambrosone CB, Hutson A, McCann SE, Tammela J, Geisler JP, Miller G, Sellers T, Cliby W, Qian F, Keitz B, Intengan M, Lele S, Alderfer JL. Odunsi K, et al. Int J Cancer. 2005 Feb 20;113(5):782-8. doi: 10.1002/ijc.20651. Int J Cancer. 2005. PMID: 15499633

4

Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer.

Hylander B, Repasky E, Shrikant P, Intengan M, Beck A, Driscoll D, Singhal P, Lele S, Odunsi K. Hylander B, et al. Gynecol Oncol. 2006 Apr;101(1):12-7. doi: 10.1016/j.ygyno.2005.09.052. Epub 2005 Nov 2. Gynecol Oncol. 2006. PMID: 16263157

5

Tumors of low malignant potential arising in the fallopian tube: case reports.

Villella JA, Pauli SA, Wang J, Intengan M, Lele S. Villella JA, et al. Eur J Gynaecol Oncol. 2005;26(3):327-9. Eur J Gynaecol Oncol. 2005. PMID: 15991538

6

Pregnancy coexisting with serous papillary adenocarcinoma involving both uterus and ovary.

Fine BA, Baker TR, Hempling RE, Intengan M. Fine BA, et al. Gynecol Oncol. 1994 Jun;53(3):369-72. doi: 10.1006/gyno.1994.1150. Gynecol Oncol. 1994. PMID: 8206413

7

Local invasion of prostate carcinoma causing vesicorectal fistula.

Corral DA, Rodriguez-Bigas MA, Intengan M. Corral DA, et al. J Urol. 2000 Nov;164(5):1662-3. J Urol. 2000. PMID: 11025738 No abstract available.

8

Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma.

Khoury T, Tan D, Wang J, Intengan M, Yang J, Alrawi S, Yan P, Byrd JC. Khoury T, et al. BMC Clin Pathol. 2006 Jan 12;6:1. doi: 10.1186/1472-6890-6-1. BMC Clin Pathol. 2006. PMID: 16409624 Free PMC article.

9

Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma.

Pejovic T, Ladner D, Intengan M, Zheng K, Fairchild T, Dillon D, Easley S, Dillon D, Marchetti D, Schwartz P, Lele S, Costa J, Odunsi K. Pejovic T, et al. Eur J Cancer. 2004 Nov;40(16):2519-24. doi: 10.1016/j.ejca.2004.07.009. Eur J Cancer. 2004. PMID: 15519528

10

Gastrointestinal stromal tumor: chondro-myxoid variant mimicking chondrosarcoma.

Rajput A, Levea C, Intengan M, Kane J, Gibbs JF. Rajput A, et al. Sarcoma. 2005;9(1-2):25-8. doi: 10.1080/13577140500043708. Sarcoma. 2005. PMID: 18521413 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters